See also this year's filing and all EDGAR filings for this company.
PDF Report 0001347613_2012_Synergy_Pharmaceuticals_LLC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | NetIncome node detected by IncomeLoss name heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001347613, Synergy Pharmaceuticals LLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,308,285 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,773 |
| 3 | remainder_Assets | 1,555,481 |
| 4 | LiabilitiesCurrent | 2,746,999 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,325,114 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,745,642 |
| 9 | ResearchAndDevelopmentExpense | 13,418,754 |
| 10 | remainder_Expenses | 28,156,502 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,697,360 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 15,869,539 |
| 1 | Liabilities | 6,072,113 |
| 2 | Expenses | 48,320,898 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 9,797,426 |
| 5 | NetIncome | -42,623,538 |
| 6 | ComprehensiveNetIncome | -42,623,538 |
| 7 | BaseVar | 37,979,955 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.94 |
| 9 | EconomicCapitalRatio | 1.04 |
Edgar->Model Mapping
Feature Distribution
